Neuropsychiatric Symptoms and Global Functional Impairment along the Alzheimers Continuum
Lauren P. Wadsworth(Massachusetts General Hospital), Gad A. Marshall, Nancy J. Donovan(Brigham and Women's Hospital), Dorene M. Rentz(Harvard University), Natacha Lorius(Brigham and Women's Hospital), Keith A. Johnson(Jacobson Holman (United States)), Joseph J. Locascio(Jacobson Holman (United States)), Reisa A. Sperling(Brigham and Women's Hospital)
Cited by 139
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k